{"id":8269,"date":"2024-09-24T09:57:37","date_gmt":"2024-09-24T14:57:37","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=eventos&#038;p=8269"},"modified":"2024-10-10T11:54:47","modified_gmt":"2024-10-10T16:54:47","slug":"fifarma-w-a-i-t-indicator-2024","status":"publish","type":"eventos","link":"https:\/\/fifarma.org\/pt\/eventos\/fifarma-w-a-i-t-indicator-2024\/","title":{"rendered":"FIFARMA W.A.I.T. Indicator 2024"},"content":{"rendered":"<h2 class=\"wp-block-heading\">Pacientes latino-americanos devem esperar em m\u00e9dia 4,7 anos para ter acesso a tratamentos inovadores ou de ponta<\/h2>\n\n\n\n<p><em>Um medicamento aprovado pela ag\u00eancia reguladora dos Estados Unidos (FDA) em outubro de 2024 s\u00f3 estar\u00e1 dispon\u00edvel ao p\u00fablico nos sistemas de sa\u00fade latino-americanos em agosto de 2029 (em m\u00e9dia).<\/em><\/p>\n\n\n\n<p id=\"ember4089\"><strong>9 de outubro de 2024<\/strong>. A FIFARMA lan\u00e7ou a terceira edi\u00e7\u00e3o do relat\u00f3rio W.A.I.T Indicator 2024, que mede os tempos de acesso a medicamentos inovadores na Am\u00e9rica Latina.<\/p>\n\n\n\n<p id=\"ember4090\">O relat\u00f3rio de 2024 abrange cinco \u00e1reas terap\u00eauticas: oncologia, doen\u00e7as \u00f3rf\u00e3s, imunol\u00f3gicas e inflamat\u00f3rias, sistema nervoso central e cardiometab\u00f3lica. No total, foram monitoradas 365 mol\u00e9culas ou tratamentos aprovados pelas ag\u00eancias reguladoras dos Estados Unidos (<a href=\"https:\/\/www.fda.gov\/\"><strong>FDA<\/strong><\/a>) e a Uni\u00e3o Europeia (<a href=\"https:\/\/www.ema.europa.eu\/en\/homepage\"><strong>EMA<\/strong><\/a>) nos \u00faltimos dez anos (2014-2023). Estas mol\u00e9culas representam 80% de todas as novas subst\u00e2ncias ativas (NSA) lan\u00e7adas internacionalmente no per\u00edodo do estudo. O n\u00famero de pa\u00edses analisados \u200b\u200btamb\u00e9m \u00e9 ampliado para dez: Argentina, Brasil, Chile, Col\u00f4mbia, Costa Rica, Equador, M\u00e9xico, Panam\u00e1, Peru e Rep\u00fablica Dominicana.<\/p>\n\n\n\n<p id=\"ember4091\"><strong>Principais resultados do relat\u00f3rio<\/strong><\/p>\n\n\n\n<p id=\"ember4092\"><strong>H\u00e1 disponibilidade limitada de medicamentos inovadores ou de pr\u00f3xima gera\u00e7\u00e3o na Am\u00e9rica Latina<\/strong>. 61% dos medicamentos aprovados internacionalmente (FDA ou EMA) t\u00eam aprova\u00e7\u00e3o regulamentar local em pelo menos um pa\u00eds, mas apenas 35% t\u00eam disponibilidade p\u00fablica total ou parcial. No caso dos tratamentos mais recentes, a disponibilidade \u00e9 consideravelmente reduzida. Dos medicamentos aprovados internacionalmente em 2020, menos de 12% tinham disponibilidade p\u00fablica total ou parcial na nossa regi\u00e3o, indicando que a inova\u00e7\u00e3o n\u00e3o est\u00e1 a chegar aos pacientes ao ritmo que ocorre.<\/p>\n\n\n\n<p id=\"ember4093\"><strong>Os tempos de espera s\u00e3o longos para o acesso a medicamentos de \u00faltima gera\u00e7\u00e3o. <\/strong>Na Am\u00e9rica Latina, um novo medicamento pode levar em m\u00e9dia 4,75 anos para ter disponibilidade p\u00fablica, limitada ou completa ap\u00f3s aprova\u00e7\u00e3o regulat\u00f3ria nos Estados Unidos (FDA) ou na Uni\u00e3o Europeia (EMA). Nessas condi\u00e7\u00f5es, um medicamento aprovado pela FDA ou EMA em outubro de 2024 s\u00f3 estar\u00e1 dispon\u00edvel ao p\u00fablico nos sistemas de sa\u00fade latino-americanos em agosto de 2029.<\/p>\n\n\n\n<p id=\"ember4094\">\u201cUm caso identificado pelo estudo, que mostra claramente os atrasos nos processos de aprova\u00e7\u00e3o e acesso, \u00e9 o dos tratamentos para <strong>doen\u00e7as \u00f3rf\u00e3s e oncol\u00f3gicas, onde 87% n\u00e3o tiveram qualquer progresso no seu processo<\/strong> de aprova\u00e7\u00e3o regulat\u00f3ria ou acesso p\u00fablico no \u00faltimo ano (2023-2024) na Am\u00e9rica Latina.\u201d men\u00e7\u00e3o <a href=\"https:\/\/www.linkedin.com\/in\/andreballalai\/\"><strong>Andre Ballalai<\/strong><\/a>, <strong>Associado S\u00eanior da IQVIA e l\u00edder de projeto<\/strong>.<\/p>\n\n\n\n<p id=\"ember4095\">\u201cA aprova\u00e7\u00e3o regulamentar, os prazos de reembolso e o acesso a medicamentos inovadores na regi\u00e3o enfrentam atrasos significativos. Em pa\u00edses como Col\u00f4mbia, Chile e M\u00e9xico, estes processos excedem a m\u00e9dia regional, demorando mais de 5 anos. Relat\u00f3rios como o W.A.I.T nos fornecem dados fundamentais para analisar esta complexa realidade. S\u00f3 com a compreens\u00e3o do ambiente de sa\u00fade da regi\u00e3o poderemos promover espa\u00e7os de di\u00e1logo e colabora\u00e7\u00e3o que nos permitam tra\u00e7ar um roteiro claro para reduzir os tempos de acesso, colocando sempre os pacientes no centro da conversa. \u201cEsta \u00e9 uma responsabilidade partilhada e na FIFARMA assumimos esse compromisso como prioridade.\u201d afirmou <a href=\"https:\/\/www.linkedin.com\/in\/yaneth-giha\/\"><strong>Yaneth Giha<\/strong><\/a><strong>, Diretor Executivo da FIFARMA.<\/strong><\/p>\n\n\n\n<p>O FIFARMA W.A.I.T. (<em>Waiting to Access to Innovative Therapies<\/em>) O indicador 2024 foi elaborado por <a href=\"https:\/\/www.iqvia.com\/\"><strong>IQVIA<\/strong><\/a>, empresa multinacional l\u00edder em pesquisa e an\u00e1lise avan\u00e7ada na \u00e1rea de ci\u00eancias da sa\u00fade, em estreita colabora\u00e7\u00e3o com a equipe FIFARMA e associa\u00e7\u00f5es locais da ind\u00fastria farmac\u00eautica.<\/p>\n\n\n\n<p><br><\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-a89b3969 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/fifarma.org\/pt\/waitindicator2024\/\" target=\"_blank\" rel=\"noreferrer noopener\">Baixe aqui<\/a><\/div>\n<\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"112\" src=\"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/Header-press-1-1024x112.png\" alt=\"\" class=\"wp-image-8288\" srcset=\"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/Header-press-1-1024x112.png 1024w, https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/Header-press-1-300x33.png 300w, https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/Header-press-1-768x84.png 768w, https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/Header-press-1-1536x169.png 1536w, https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/Header-press-1-18x2.png 18w, https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/Header-press-1.png 1584w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div>","protected":false},"featured_media":8275,"parent":0,"template":"","tipo-de-evento":[],"categoria-evento":[],"class_list":["post-8269","eventos","type-eventos","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FIFARMA W.A.I.T. Indicator 2024 - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/eventos\/fifarma-w-a-i-t-indicator-2024\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FIFARMA W.A.I.T. Indicator 2024\" \/>\n<meta property=\"og:description\" content=\"Los pacientes latinoamericanos deben esperar en promedio 4.7 a\u00f1os para acceder a tratamientos innovadores o de \u00faltima generaci\u00f3n Un medicamento aprobado por la agencia regulatoria de los Estados Unidos (FDA) en octubre de 2024, solo estar\u00e1 disponible al p\u00fablico en los sistemas de salud latinoamericanos en agosto de 2029 (en promedio). 9 de octubre de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/eventos\/fifarma-w-a-i-t-indicator-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-10T16:54:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/DALL\u00b7E-2024-09-24-09.55.45-A-realistic-photograph-showing-a-healthcare-professional-dressed-in-a-white-coat-with-a-stethoscope-around-their-neck-holding-the-hands-of-a-patient.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1792\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/eventos\\\/fifarma-w-a-i-t-indicator-2024\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/eventos\\\/fifarma-w-a-i-t-indicator-2024\\\/\",\"name\":\"FIFARMA W.A.I.T. Indicator 2024 - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/eventos\\\/fifarma-w-a-i-t-indicator-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/eventos\\\/fifarma-w-a-i-t-indicator-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/DALL\u00b7E-2024-09-24-09.55.45-A-realistic-photograph-showing-a-healthcare-professional-dressed-in-a-white-coat-with-a-stethoscope-around-their-neck-holding-the-hands-of-a-patient.webp\",\"datePublished\":\"2024-09-24T14:57:37+00:00\",\"dateModified\":\"2024-10-10T16:54:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/eventos\\\/fifarma-w-a-i-t-indicator-2024\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/eventos\\\/fifarma-w-a-i-t-indicator-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/eventos\\\/fifarma-w-a-i-t-indicator-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/DALL\u00b7E-2024-09-24-09.55.45-A-realistic-photograph-showing-a-healthcare-professional-dressed-in-a-white-coat-with-a-stethoscope-around-their-neck-holding-the-hands-of-a-patient.webp\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/DALL\u00b7E-2024-09-24-09.55.45-A-realistic-photograph-showing-a-healthcare-professional-dressed-in-a-white-coat-with-a-stethoscope-around-their-neck-holding-the-hands-of-a-patient.webp\",\"width\":1792,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/eventos\\\/fifarma-w-a-i-t-indicator-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eventos\",\"item\":\"https:\\\/\\\/fifarma.org\\\/eventos\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FIFARMA W.A.I.T. Indicator 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FIFARMA W.A.I.T. Indicator 2024 - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/eventos\/fifarma-w-a-i-t-indicator-2024\/","og_locale":"pt_BR","og_type":"article","og_title":"FIFARMA W.A.I.T. Indicator 2024","og_description":"Los pacientes latinoamericanos deben esperar en promedio 4.7 a\u00f1os para acceder a tratamientos innovadores o de \u00faltima generaci\u00f3n Un medicamento aprobado por la agencia regulatoria de los Estados Unidos (FDA) en octubre de 2024, solo estar\u00e1 disponible al p\u00fablico en los sistemas de salud latinoamericanos en agosto de 2029 (en promedio). 9 de octubre de [&hellip;]","og_url":"https:\/\/fifarma.org\/pt\/eventos\/fifarma-w-a-i-t-indicator-2024\/","og_site_name":"FIFARMA","article_modified_time":"2024-10-10T16:54:47+00:00","og_image":[{"width":1792,"height":1024,"url":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/DALL\u00b7E-2024-09-24-09.55.45-A-realistic-photograph-showing-a-healthcare-professional-dressed-in-a-white-coat-with-a-stethoscope-around-their-neck-holding-the-hands-of-a-patient.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/eventos\/fifarma-w-a-i-t-indicator-2024\/","url":"https:\/\/fifarma.org\/eventos\/fifarma-w-a-i-t-indicator-2024\/","name":"FIFARMA W.A.I.T. Indicator 2024 - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fifarma.org\/eventos\/fifarma-w-a-i-t-indicator-2024\/#primaryimage"},"image":{"@id":"https:\/\/fifarma.org\/eventos\/fifarma-w-a-i-t-indicator-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/DALL\u00b7E-2024-09-24-09.55.45-A-realistic-photograph-showing-a-healthcare-professional-dressed-in-a-white-coat-with-a-stethoscope-around-their-neck-holding-the-hands-of-a-patient.webp","datePublished":"2024-09-24T14:57:37+00:00","dateModified":"2024-10-10T16:54:47+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/eventos\/fifarma-w-a-i-t-indicator-2024\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/eventos\/fifarma-w-a-i-t-indicator-2024\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/eventos\/fifarma-w-a-i-t-indicator-2024\/#primaryimage","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/DALL\u00b7E-2024-09-24-09.55.45-A-realistic-photograph-showing-a-healthcare-professional-dressed-in-a-white-coat-with-a-stethoscope-around-their-neck-holding-the-hands-of-a-patient.webp","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/09\/DALL\u00b7E-2024-09-24-09.55.45-A-realistic-photograph-showing-a-healthcare-professional-dressed-in-a-white-coat-with-a-stethoscope-around-their-neck-holding-the-hands-of-a-patient.webp","width":1792,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/eventos\/fifarma-w-a-i-t-indicator-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Eventos","item":"https:\/\/fifarma.org\/eventos\/"},{"@type":"ListItem","position":3,"name":"FIFARMA W.A.I.T. Indicator 2024"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federa\u00e7\u00e3o Latino-Americana da Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/eventos\/8269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/eventos"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/eventos"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media\/8275"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=8269"}],"wp:term":[{"taxonomy":"tipo-de-evento","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/tipo-de-evento?post=8269"},{"taxonomy":"categoria-evento","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categoria-evento?post=8269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}